| Title |
Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, August 2013
|
| DOI | 10.2147/ndt.s49080 |
| Pubmed ID | |
| Authors |
Jose Manuel Olivares, Manickam Thirunavukarasu, Jayashri Kulkarni, Hong Yan Zhang, Mingyuan Zhang, Fan Zhang |
| Abstract |
Nonadherence is a well-known problem among schizophrenia patients, among whom relapse is fivefold more likely, adversely affecting health, employment, and social functioning. The Spanish Adherencia Terapéutica en la Esquizofrenia (ADHES) survey was developed to determine the scope and causes of medication nonadherence in schizophrenia. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| Bangladesh | 1 | 1% |
| Unknown | 68 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 21% |
| Student > Bachelor | 10 | 14% |
| Other | 9 | 13% |
| Student > Master | 7 | 10% |
| Student > Ph. D. Student | 6 | 9% |
| Other | 8 | 11% |
| Unknown | 15 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 19 | 27% |
| Medicine and Dentistry | 18 | 26% |
| Nursing and Health Professions | 5 | 7% |
| Agricultural and Biological Sciences | 3 | 4% |
| Neuroscience | 3 | 4% |
| Other | 6 | 9% |
| Unknown | 16 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2013.
All research outputs
#17,286,379
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,901
of 3,132 outputs
Outputs of similar age
#132,644
of 210,078 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#49
of 66 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,078 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.